Li Shen

Li Shen is a patent litigator at Tensegrity Law Group, specializing in a broad range of technologies, including biotechnology, pharmaceutics, software, fintech, and telecommunication. Her practice involves U.S. district courts, the Patent Trial and Appeal Board (PTAB), and the International Trade Commission.

Shen's case appearances predominantly involve plaintiff-side representation, aligning with her firm's focus on patent enforcement. Her tracked experience includes serving as of counsel and pro hac vice for 10x Genomics, Inc. in patent infringement actions.

Notable matters include her involvement in 10x Genomics, Inc. et al. v. Vizgen, Inc., a dispute concerning gene-mapping technologies that settled in February 2025 during trial in the District of Delaware. She is also involved in 10x Genomics, Inc. et al. v. Element Biosciences, Inc., a case filed in May 2026 alleging infringement of patents related to next-generation sequencing technology. As part of Tensegrity Law Group's patent litigation team, she contributes to a practice that has secured significant outcomes for clients, including jury trial victories and ITC exclusion orders in complex technology cases.

Prior to joining Tensegrity Law Group in 2022, Shen was a managing associate at Orrick, Herrington & Sutcliffe. She gained judicial externship experience during law school, working for Judge S. James Otero in the Central District of California and Judge Alex Kozinski in the Ninth Circuit Court of Appeals.